GRCE

$1.87+3.31%visit website download financials (.py)

Grace Therapeutics, Inc.

Market Cap

$30M

Live price × shares (2026-10-17)

Sector

Health Care

Industry

Pharmaceuticals

Beta (raw)

0.32

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

0.3

Price / TTM revenue

P/B

0.6

Price / stockholders equity

EV/EBITDA

—

TTM

Price Chart

Loading…

Signals

purchases / sales, 90d

Short Volume

46%

W/W +1.0pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro →

Velocity Score

24.85x

Avg Daily Buying (90d)

4,311 sh/day

Baseline Daily Buying

0.0 sh/day

Unique Buyers (90d)

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-10-26	2026-10-26	Opaleye Management Inc.	10% Owner	Purchase	66.4K	$1.77	$117K	3.04M	View
2026-10-22	2026-10-26	Opaleye Management Inc.	10% Owner	Purchase	21.4K	$1.93	$41K	2.97M	View
2026-10-19	2026-10-21	Opaleye Management Inc.	10% Owner	Purchase	4,256	$1.88	$8K	2.95M	View
2026-10-16	2026-10-16	Opaleye Management Inc.	10% Owner	Purchase	36.3K	$1.89	$69K	2.94M	View
2026-10-15	2026-10-16	Opaleye Management Inc.	10% Owner	Purchase	23.5K	$1.95	$46K	2.91M	View

1–5 of 19

1 / 4

GRCE

Signals

Factor Profile

Recent News

Grace Therapeutics, Inc. (GRCE)

Reporting Insiders

Factor Profile

Date	Insider	Type	Shares	Value
2026-10-26	Opaleye Management Inc.	P	66,411	$117,408.01
2026-10-22	Opaleye Management Inc.	P	21,390	$41,192.86
2026-10-19	Opaleye Management Inc.	P	4,256	$8,001.28
2026-10-16	Opaleye Management Inc.	P	36,347	$68,757.62
2026-10-15	Opaleye Management Inc.	P	23,485	$45,685.37